Private Advisor Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,124
Closed -$130K 1866
2022
Q3
$130K Sell
15,124
-300
-2% -$2.98K ﹤0.01% 1748
2022
Q2
$126K Buy
15,424
+1,355
+10% +$12.9K ﹤0.01% 1923
2022
Q1
$171K Sell
14,069
-4,960
-26% -$104K ﹤0.01% 1925
2021
Q4
$649K Sell
19,029
-875
-4% -$34.3K ﹤0.01% 1321
2021
Q3
$960K Buy
19,904
+3,275
+20% +$152K 0.01% 1228
2021
Q2
$751K Buy
16,629
+1,800
+12% +$79.8K 0.01% 1207
2021
Q1
$715K Sell
14,829
-12,352
-45% -$643K 0.01% 1149
2020
Q4
$1.46M Buy
27,181
+5,456
+25% +$247K 0.02% 768
2020
Q3
$801K Buy
21,725
+1,810
+9% +$67.3K 0.01% 875
2020
Q2
$617K Buy
19,915
+880
+5% +$24.4K 0.01% 936
2020
Q1
$526K Buy
19,035
+589
+3% +$17.6K 0.01% 876
2019
Q4
$540K Buy
18,446
+8,252
+81% +$197K 0.01% 1011
2019
Q3
$195K Buy
+10,194
New +$239K ﹤0.01% 1512

Other funds holding NEO

Private Advisor Group's NEO Position: Q4 2022 in Review

Private Advisor Group sold out of NeoGenomics (NEO) in Q4 2022, closing a stake of 15,124 shares — an estimated $130K sold.

Private Advisor Group first reported a position in NEO in Q3 2019 and held it in 13 quarters. The position peaked at $1.46M in Q4 2020. 242 funds tracked by Wall St. Rank hold NEO as of Q4 2022.

  • Private Advisor Group reported no remaining NeoGenomics position as of Q4 2022 after selling out during the quarter.
  • Private Advisor Group sold 15,124 NeoGenomics shares in Q4 2022, an estimated $130K.
  • Private Advisor Group first reported a position in NeoGenomics in Q3 2019 and held it in 13 quarters.
  • Private Advisor Group's NeoGenomics position peaked at $1.46M in Q4 2020.
  • 242 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2022.

Based on Private Advisor Group's 13F filing for Q4 2022, filed 18 Jan 2023.